Psychedelic Society of Philadelphia
Philadelphia's primary psychedelic community organization — adjacent to Penn Medicine's growing psychedelic research program and the University of Pennsylvania's clinical trial infrastructure.
Type: Community
Location: Philadelphia, PA
Members: 1,600+
Membership: Open community access
Venues: Philadelphia community spaces; rotating locations
Activities: Monthly integration circles, harm reduction education, speaker series, community support for psychedelic experiences, connection to Penn Medicine and Jefferson Health researchers.
About
Psychedelic Society of Philadelphia operates with approximately 1,600+ members, hosting integration circles, harm reduction education, and a speaker series drawing on Philadelphia's substantial academic medical complex. Penn Medicine (University of Pennsylvania) has developed one of the more active psychedelic research programs on the East Coast, and Thomas Jefferson University has also begun clinical trial work in the space — giving the Philadelphia psychedelic community closer proximity to active research than most comparable cities.
Pennsylvania's regulatory environment remains conservative — there is no state-level psilocybin reform as of 2026 — so the Society operates entirely in an educational and integration-support capacity. Programming focuses on preparing the community for eventual access while supporting the large existing population using psilocybin outside formal therapeutic settings.
The Society also serves as an advocacy hub, providing community members with resources to engage their state and local representatives on psychedelic policy.
Why It Matters
Philadelphia's combination of major academic medical center research capacity and a large urban population interested in psychedelic therapy makes it one of the most important mid-Atlantic cities for community infrastructure development.
State Legal Context
See current psilocybin laws in Pennsylvania.